Top Tweets for #IMmotion151
Beautiful commentary - I particularly like the figure below that juxtaposes data from #IMmotion151 from @motzermd et al against data from #JAVELIN100 from @ReneeSaliby @DrChoueiri @BraunMDPhD et al. Very nicely done, @chadihc98 @neerajaiims @huntsmancancer!
Just in @Cancer_Cell 👉Validation of the molecular clusters of the IMmotion151 trial in the JAVELIN Renal 101 dataset #kidneycancer: Excellent commentary highlighting these biomarkers by our fellow @chadihc98 👇https://t.co/6FT646QLW5 @Huntsman_GU @OncoAlert @urotoday @kidneycan
Proud mentor @DrChoueiri overseeing two stars, @Chrislabaki1 & @ReneeSaliby, during #KCRS22. Amazing to see the opportunities he has given @DanaFarber fellows over the years! Terrific data re: pushing #Immotion151 sigs into #JR101 & #chromophobe #kidneycancer.
In the phase III #IMmotion151 trial of metastatic #RenalCellCarcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score. #ReadNow on UroToday > https://t.co/q4vIPEX7Bo @Annals_Oncology @UniklinikBonn @IEO_HolzelLab
In the phase III #IMmotion151 trial of metastatic #RenalCellCarcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score. #ReadNow on UroToday > https://t.co/q4vIPEFwcO @Annals_Oncology @UniklinikBonn @IEO_HolzelLab
#IMmotion151 subgroup analysis. Pts w/ mRCC - patients with sarcomatoid features had increased overall survival with atezo+bev vs sunitinib, regardless of PD-L1 status. @brian_rini @ClevelandClinic. Coverage by @TheRealJasonZhu @DukeCancer on UroToday. https://t.co/38ipUOxpax
On the other hand, PD-L1 expression didn't predict benefit on single agent Nivolumab but correlated with better outcomes in patients receiving ICI combinations (#CheckMate-214, #KEYNOTE-426, #IMmotion151, #JAVELINRENAL101).
Role of PD-L1 as a biomarker --> still controversial.
#IMmotion151 subgroup analysis. Pts w/ mRCC - patients with sarcomatoid features had increased overall survival with atezo+bev vs sunitinib, regardless of PD-L1 status. @brian_rini @ClevelandClinic. Coverage by @TheRealJasonZhu @DukeCancer on UroToday. https://t.co/38ipUOxpax
The challenges faced by established frontline therapies in renal cancer. @AlbigesL @GustaveRoussy #Checkmate214, #IMmotion151, and #JAVELIN101, #Keynote426 @GoldbergHanan @pmcancercentre covers: https://t.co/2OvKLANdus
#IMmotion151 update in @TheLancet: Atezolizumab plus Bevacizumab versus Sunitinib in mRCC. Prolonged PFS with A+B, but no significant improvement in OS. Slightly better toxicity profiles. What's next? #clinicaltrials #cancer #Immunotherapy https://t.co/Q3DpIMiDct
Also from @EMA_News last week: Withdrawal of application for a change to the marketing authorisation for Tecentriq (atezolizumab) - (plus bev) pending additional data collection from ongoing trial #kidneycancer #imMotion151 https://t.co/xon6OLnJbW
We had a chance to ask Dr. Rini from @ClevelandClinic to discuss subgroup findings from the IMmotion151 trial in metastatic renal cell carcinoma at #ESMO18. Check it out this quick clip from our interview here: https://t.co/Ac91h2ee2H
#KidneyCancer #kcsm #Immotion151
.@DrChoueiri , Director of the Lank Center for GU Oncology at @DanaFarber , shares top abstracts in #genitourinary #oncology presented at ASCO 2018, such as #IMmotion151, the #PROSPER trial, #Carmena, and more! Live now on @OncologyGo. https://t.co/tD1y9kbWQv
Trial updates in #mRCC from ASCO: KEYNOTE-427, RESORT, #E2810 & #IMmotion151 @DrChoueiri @DanaFarber @VJOncology #ASCO18 https://t.co/JItNIOxCed
#ASCO18 news: #IMmotion151 patient-reported outcomes add support for first-line #atezolizumab plus #bevacizumab in patients with metastatic #RCC. #kidneycancer Reported by Bernard Escudier @ASCO https://t.co/P5KK1R7Y8X
Not all #IO equal for #kidneycancer? No OS benefit so far for atezo/bev in #IMMOTION151. Did include sarcomatoid RCC, sunitinib arm might be fraction worse than #CHECKMATE214 @IKCCorg @ANZUPtrials @ASCO #GU18
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers